tiprankstipranks
Trending News
More News >
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market

Lexaria Bioscience (LEXX) Cash flow

Compare
237 Followers

Lexaria Bioscience Cash Flow

LEXX's free cash flow for Q3 2025 was $-3.58M. For the 2025 fiscal year, LEXX's free cash flow was decreased by $-5.45M and operating cash flow was $-3.58M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -10.45M$ -4.96M$ -5.88M$ -4.88M$ -3.99M
Investing Cash Flow
$ -243.02K$ -188.60K$ -169.61K$ -180.64K$ 193.88K
Financing Cash Flow
$ 6.05M$ 10.32M$ 1.59M$ -44.60K$ 13.42M
End Cash Position
$ 1.80M$ 6.50M$ 1.35M$ 5.81M$ 10.92M
Free Cash Flow
$ -10.45M$ -5.00M$ -6.05M$ -5.01M$ -4.07M
Currency in USD

Lexaria Bioscience Cash Flow